Last reviewed · How we verify
ZH9PA and ZH9 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
ZH9PA and ZH9 (ZH9PA and ZH9) — Prokarium Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ZH9PA and ZH9 TARGET | ZH9PA and ZH9 | Prokarium Ltd | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ZH9PA and ZH9 CI watch — RSS
- ZH9PA and ZH9 CI watch — Atom
- ZH9PA and ZH9 CI watch — JSON
- ZH9PA and ZH9 alone — RSS
Cite this brief
Drug Landscape (2026). ZH9PA and ZH9 — Competitive Intelligence Brief. https://druglandscape.com/ci/zh9pa-and-zh9. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab